Paid Clinical Trials for Cancer, -----

Paid Clinical Trials and Focus Groups by Category

Find Paid Clinical Trials

Find Paid Clinical Trials All Categories ... by Medical Condition » ... Cancers » ... AIDS Related


  • Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

    Condition:   Sarcoma
    Interventions:   Drug: bortezomib;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
    Sponsors:   AIDS Associated Malignancies Clinical Trials Consortium;   National Cancer Institute (NCI)
    Recruiting - verified March 2010
  • Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

    Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Methemoglobinemia;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nonmalignant Neoplasm
    Interventions:   Drug: chemotherapy;   Drug: dapsone;   Other: medical chart review;   Procedure: assessment of therapy complications
    Sponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified December 2009
  • Collecting and Storing Blood Samples From Patients With Cancer

    Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nonmalignant Neoplasm;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
    Intervention:   Other: biologic sample preservation procedure
    Sponsors:   Cancer Institute of New Jersey;   National Cancer Institute (NCI)
    Recruiting - verified August 2008
  • Studying Fentanyl in Patients With Cancer

    Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Precancerous Condition;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: fentanyl citrate;   Other: pharmacological study
    Sponsors:   Sidney Kimmel Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified July 2009
  • Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

    Conditions:   Lymphoma;   Small Intestine Cancer
    Interventions:   Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: indium In 111-labeled autologous peripheral blood mononuclear cells;   Radiation: indium In 111-labeled autologous polymorphonuclear leukocytes
    Sponsors:   Holden Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified March 2007
  • Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy

    Conditions:   Chronic Myeloproliferative Disorders;   Kidney Cancer;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Nonneoplastic Condition;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: sunitinib malate;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
    Sponsors:   AIDS Associated Malignancies Clinical Trials Consortium;   National Cancer Institute (NCI)
    Recruiting - verified March 2010
  • Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers

    Conditions:   Chronic Myeloproliferative Disorders;   Depression;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Psychosocial Effects of Cancer and Its Treatment;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Other: medical chart review;   Other: questionnaire administration;   Procedure: psychosocial assessment and care
    Sponsors:   Cancer Institute of New Jersey;   National Cancer Institute (NCI)
    Recruiting - verified August 2008
  • Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

    Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Unspecified Adult Solid Tumor, Protocol Specific
    Intervention:   Other: educational intervention
    Sponsors:   Fox Chase Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified July 2009
  • Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

    Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Pain;   Precancerous Condition;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: methadone hydrochloride;   Drug: morphine sulfate;   Drug: oxycodone hydrochloride
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified June 2009
  • Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials

    Conditions:   Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
    Interventions:   Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Other: laboratory biomarker analysis;   Procedure: colposcopic biopsy
    Sponsors:   AIDS Associated Malignancies Clinical Trials Consortium;   National Cancer Institute (NCI)
    Recruiting - verified March 2010
  • PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma

    Conditions:   Nonneoplastic Condition;   Sarcoma
    Interventions:   Drug: anti-VEGF small molecule PTC299;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy
    Sponsors:   AIDS Associated Malignancies Clinical Trials Consortium;   National Cancer Institute (NCI);   PTC Therapeutics Incorporated
    Recruiting - verified March 2010
  • Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

    Condition:   Lymphoma
    Interventions:   Biological: rituximab;   Drug: bortezomib;   Drug: carboplatin;   Drug: dexamethasone;   Drug: etoposide;   Drug: ifosfamide;   Genetic: polymerase chain reaction;   Genetic: western blotting;   Other: questionnaire administration
    Sponsors:   AIDS Associated Malignancies Clinical Trials Consortium;   National Cancer Institute (NCI)
    Recruiting - verified March 2010
  • Studying Patients With a Personal or Family History of Cancer Caused by a Virus

    Conditions:   Lymphoma;   Lymphoproliferative Disorder;   Sarcoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
    Interventions:   Other: biologic sample preservation procedure;   Other: cytology specimen collection procedure;   Other: immunologic technique;   Procedure: biopsy;   Procedure: study of high risk factors
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified August 2009
  • Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

    Condition:   Cancer
    Interventions:   Drug: fentanyl sublingual spray;   Other: questionnaire administration
    Sponsor:   Insys Therapeutics Inc
    Recruiting - verified October 2008
  • Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma

    Conditions:   Brain and Central Nervous System Tumors;   Lymphoma;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Biological: bevacizumab;   Drug: cediranib maleate;   Genetic: TdT-mediated dUTP nick end labeling assay;   Other: flow cytometry;   Other: fluorescent antibody technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified June 2009
  • Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

    Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Metastatic Cancer;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous Condition;   Secondary Myelofibrosis;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Drug: pemetrexed disodium;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsor:   Robert H. Lurie Cancer Center
    Recruiting - verified July 2009
  • Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

    Condition:   Lymphoma
    Interventions:   Biological: filgrastim;   Biological: pegfilgrastim;   Biological: rituximab;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: leucovorin calcium;   Drug: liposomal cytarabine;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate
    Sponsors:   AIDS Associated Malignancies Clinical Trials Consortium;   National Cancer Institute (NCI)
    Recruiting - verified March 2010
  • Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

    Conditions:   Leukemia;   Lymphoma
    Interventions:   Biological: filgrastim;   Biological: rituximab;   Drug: carboplatin;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: ifosfamide;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy;   Radiation: total-body irradiation
    Sponsors:   Masonic Cancer Center, University of Minnesota;   National Cancer Institute (NCI)
    Recruiting - verified July 2009
  • Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

    Conditions:   Brain and Central Nervous System Tumors;   Carcinoma of Unknown Primary;   Leukemia;   Lymphoma;   Metastatic Cancer;   Unspecified Childhood Solid Tumor, Protocol Specific
    Intervention:   Drug: topotecan hydrochloride
    Sponsors:   Pediatric Brain Tumor Consortium;   National Cancer Institute (NCI)
    Recruiting - verified April 2008
  • Screening Individuals and Families at High Risk for Hematologic Cancers

    Conditions:   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: genetic linkage analysis;   Genetic: microarray analysis;   Other: counseling intervention;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: evaluation of cancer risk factors
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified April 2007

Main Menu

Find Clinical Trials